Press release
Global Migraine Therapeutics Market is Expected to Reach USD 9.50 Billion, Growing at a CAGR of 9% between 2023 and 2030 | IGR
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/481
Market Insight:
The global migraine therapeutics market, surpassing a value of USD 4.70 billion in 2022, is poised to ascend to nearly USD 9.50 billion by 2030, showcasing a noteworthy CAGR of about 9% during the forecast period from 2023 to 2030.
Migraine is a prevalent condition, significantly impacting women (20%) and men (8%) with its characteristic moderate to severe pulsating headaches. Treatment guidelines and preventive therapies play a pivotal role in managing this condition effectively. The market's growth is attributed to increased awareness about migraines, substantial investments in R&D, and a surge in pipeline products addressing the high unmet needs associated with migraines. Moreover, strategic initiatives like product launches, approvals, mergers, and acquisitions by key market players fuel market expansion. Despite these growth factors, medication side effects are expected to impede market growth, yet the development of novel drugs and therapies offers promising growth avenues.
Regional Analysis:
North America is slated to lead the global migraine therapeutics market, maintaining its dominance owing to a high prevalence of migraines, the adoption of novel therapeutics, and a substantial target population in the United States. Simultaneously, Asia Pacific is anticipated to witness robust growth attributed to the increasing migraine burden, adoption of novel therapeutics, and a sizable target population in the region.
Segmentation and Key Players:
The report segments the global migraine therapeutics market based on therapeutics (pain-relieving medications and preventive medications) and route of administration (oral, nasal, and injectables). Additionally, it provides insightful profiles of prominent market players such as Amgen Inc., Eli Lilly and Company, Pfizer Inc., and Novartis AG, among others, showcasing their pivotal roles in shaping the migraine therapeutics market landscape.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/481
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Migraine Therapeutics Market Highlights
2.2. Migraine Therapeutics Market Projection
2.3. Migraine Therapeutics Market Regional Highlights
Chapter 3. Global Migraine Therapeutics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter`s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Therapeutics
3.4.2. IGR-Growth Matrix Analysis by Route of Administration
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Migraine Therapeutics Market
Chapter 4. Migraine Therapeutics Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Migraine Therapeutics Market
5.2. Companies Profiles
5.2.1. Amgen Inc.
5.2.2. Vaxxinity
5.2.3. Eli Lilly and Company
5.2.4. Pfizer Inc.
5.2.5. Novartis AG
5.2.6. AEON Biopharma
5.2.7. Sosei Group Corporation
5.2.8. Satsuma Pharmaceuticals, Inc.
5.2.9. Allodynic Therapeutics
5.2.10. Trevena, Inc.
Chapter 6. Global Migraine Therapeutics Market by Therapeutics
6.1. Pain-relieving Medications
6.2. Preventive Medications
Chapter 7. Global Migraine Therapeutics Market by Route of Administration
7.1. Oral
7.2. Nasal
7.3. Injectables
Chapter 8. Global Migraine Therapeutics Market by Region 2023-2030
8.1. North America
8.1.1. North America Migraine Therapeutics Market by Therapeutics
8.1.2. North America Migraine Therapeutics Market by Route of Administration
8.1.3. North America Migraine Therapeutics Market by Country
8.1.3.1. The U.S. Migraine Therapeutics Market
8.1.3.1.1. The U.S. Migraine Therapeutics Market by Therapeutics
8.1.3.1.2. The U.S. Migraine Therapeutics Market by Route of Administration
8.1.3.2. Canada Migraine Therapeutics Market
8.1.3.2.1. Canada Migraine Therapeutics Market by Therapeutics
8.1.3.2.2. Canada Migraine Therapeutics Market by Route of Administration
8.1.3.3. Mexico Migraine Therapeutics Market
8.1.3.3.1. Mexico Migraine Therapeutics Market by Therapeutics
8.1.3.3.2. Mexico Migraine Therapeutics Market by Route of Administration
8.2. Europe
8.2.1. Europe Migraine Therapeutics Market by Therapeutics
8.2.2. Europe Migraine Therapeutics Market by Route of Administration
8.2.3. Europe Migraine Therapeutics Market by Country
8.2.3.1. Germany Migraine Therapeutics Market
8.2.3.1.1. Germany Migraine Therapeutics Market by Therapeutics
8.2.3.1.2. Germany Migraine Therapeutics Market by Route of Administration
8.2.3.2. United Kingdom Migraine Therapeutics Market
8.2.3.2.1. United Kingdom Migraine Therapeutics Market by Therapeutics
8.2.3.2.2. United Kingdom Migraine Therapeutics Market by Route of Administration
8.2.3.3. France Migraine Therapeutics Market
8.2.3.3.1. France Migraine Therapeutics Market by Therapeutics
8.2.3.3.2. France Migraine Therapeutics Market by Route of Administration
8.2.3.4. Italy Migraine Therapeutics Market
8.2.3.4.1. Italy Migraine Therapeutics Market by Therapeutics
8.2.3.4.2. Italy Migraine Therapeutics Market by Route of Administration
8.2.3.5. Rest of Europe Migraine Therapeutics Market
8.2.3.5.1. Rest of Europe Migraine Therapeutics Market by Therapeutics
8.2.3.5.2. Rest of Europe Migraine Therapeutics Market by Route of Administration
8.3. Asia Pacific
8.3.1. Asia Pacific Migraine Therapeutics Market by Therapeutics
8.3.2. Asia Pacific Migraine Therapeutics Market by Route of Administration
8.3.3. Asia Pacific Migraine Therapeutics Market by Country
8.3.3.1. China Migraine Therapeutics Market
8.3.3.1.1. China Migraine Therapeutics Market by Therapeutics
8.3.3.1.2. China Migraine Therapeutics Market by Route of Administration
8.3.3.2. Japan Migraine Therapeutics Market
8.3.3.2.1. Japan Migraine Therapeutics Market by Therapeutics
8.3.3.2.2. Japan Migraine Therapeutics Market by Route of Administration
8.3.3.3. India Migraine Therapeutics Market
8.3.3.3.1. India Migraine Therapeutics Market by Therapeutics
8.3.3.3.2. India Migraine Therapeutics Market by Route of Administration
8.3.3.4. South Korea Migraine Therapeutics Market
8.3.3.4.1. South Korea Migraine Therapeutics Market by Therapeutics
8.3.3.4.2. South Korea Migraine Therapeutics Market by Route of Administration
8.3.3.5. Australia Migraine Therapeutics Market
8.3.3.5.1. Australia Migraine Therapeutics Market by Therapeutics
8.3.3.5.2. Australia Migraine Therapeutics Market by Route of Administration
8.3.3.6. Rest of Asia-Pacific Migraine Therapeutics Market
8.3.3.6.1. Rest of Asia-Pacific Migraine Therapeutics Market by Therapeutics
8.3.3.6.2. Rest of Asia-Pacific Migraine Therapeutics Market by Route of Administration
8.4. RoW
8.4.1. RoW Migraine Therapeutics Market by Therapeutics
8.4.2. RoW Migraine Therapeutics Market by Route of Administration
8.4.3. RoW Migraine Therapeutics Market by Sub-region
8.4.3.1. Latin America Migraine Therapeutics Market
8.4.3.1.1. Latin America Migraine Therapeutics Market by Therapeutics
8.4.3.1.2. Latin America Migraine Therapeutics Market by Route of Administration
8.4.3.2. Middle East Migraine Therapeutics Market
8.4.3.2.1. Middle East Migraine Therapeutics Market by Therapeutics
8.4.3.2.2. Middle East Migraine Therapeutics Market by Route of Administration
8.4.3.3. Africa Migraine Therapeutics Market
8.4.3.3.1. Africa Migraine Therapeutics Market by Therapeutics
8.4.3.3.2. Africa Migraine Therapeutics Market by Route of Administration
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/481
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of migraine therapeutics.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Migraine Therapeutics Market is Expected to Reach USD 9.50 Billion, Growing at a CAGR of 9% between 2023 and 2030 | IGR here
News-ID: 3307018 • Views: …
More Releases from Infinium Global Research LLP
Infinium Global Research LLP Launches Comprehensive Service to Assist Foreign Co …
Pune, India - October 26, 2024 - Infinium Global Research LLP is excited to announce the launch of a dedicated service aimed at providing end-to-end support for foreign companies entering or expanding within the Indian market. With a strategic network of partnerships with top legal and consulting firms and increased presence across key Indian cities, Infinium is well-equipped to facilitate smooth market entry, operational setup, and business expansion for international…
Global Sterilization Services Market Size Worth USD 12.55 Billion By 2030 | CAGR …
Infinium Global Research, a leading provider of market intelligence, has recently launched an in-depth report on the Global Sterilization Services Market, offering comprehensive analysis and detailed insights into its segments and market trends.
The comprehensive study explores the impact of various factors such as drivers, restraints, and macro indicators on both the global and regional sterilization services market, providing crucial forecasts and dollar value projections.
To Know More Request a Sample of…
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market is Projected to Surp …
Infinium Global Research introduces a detailed analysis of the global and regional Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) market, providing an extensive study of its segments, trends, forecasts, and dollar values in their latest report. This comprehensive study empowers stakeholders in the pharmaceutical and healthcare sectors with invaluable insights into this burgeoning market.
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/420
Market Insight:
The global Proprotein Convertase Subtilisin/Kexin Type 9 market,…
Global Neuromodulation Market is Anticipated to Reach USD 7.27 Billion and Growi …
Infinium Global Research, a pioneering market intelligence firm, introduces a comprehensive report delving into the Global Neuromodulation Market, providing extensive analysis and in-depth exploration of its segments, market trends, and projections.
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/93
Market Insight:
The global neuromodulation market, valued at USD 3.51 Billion in 2022, is poised to ascend to USD 7.27 Billion by 2030, exhibiting a noteworthy CAGR of 9.59% during the forecast…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
